Clinical Trial Update: Embryonic Dopamine Cell Implants for Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of embryonic dopamine cell implants for Parkinson disease has completed. No results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Embryonic dopamine cell implants

Snippet

Sponsor: University of Colorado, Denver | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED